Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction

Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics

F. MOHAMADI, Nigel G. J. Richards, Wayne C. Guida et al. · Journal of Computational Chemistry · 1990 · 3.8K citations

Natural Sciences, Chemistry, Biomolecular Modeling +13

Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development

Qingjie Ding, Zhuming Zhang, Jinjun Liu et al. · Journal of Medicinal Chemistry · 2013 · 597 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Isabelle Ray‐Coquard, Jean‐Yves Blay, Antoîne Italiano et al. · The Lancet Oncology · 2012 · 563 citations

Medicine, Cancer Biology, Oncology +16

Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development

Binh Thanh Vu, Peter M. Wovkulich, Giacomo Pizzolato et al. · ACS Medicinal Chemistry Letters · 2013 · 382 citations · Full text

Medicine, Cancer Biology, Oncology +14

MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models

Christian Tovar, Bradford Graves, Kathryn Packman et al. · Cancer Research · 2013 · 285 citations

Medicine, Oncology, Pharmacology +14